Drug Identity
Active Ingredient
Paclitaxel
Drug Class
Antineoplastics
ATC Code
L01CD01
Status
Essential Medicine
How It Works
The concentrate must be diluted to a final Paclitaxel cone of 0.3 to 1.2 mg/ml in D5W, NS, D5NS. Administration over 3 hours is often recommended.
How to Take It
Dosage information not available for this product.
Safety Alerts
Acute porphyrias, Neutrophils less than 1
5x109 per litre, severe hepatic impairment
Important Warnings
Patients aged over 75 years with metastatic adenocarcinoma of the pancreas
Monitor blood counts, Cardiac conduction abnormalities, peripheral neuropathy, renal or hepatic failure
Ensure resuscitation equipment available
Side Effects
ArrhythmiaarthralgiafebrileneutropeniaGI disordersmyalgiaperipheral neuropathysensory neuropathytachycardiaalopeciahypotensionbone marrow suppressionbradycardiacardiac conduction defectsextravasationhypersensitivity reactions
Pregnancy & Lactation
Pregnancy
Contraindication in pregnancy
Lactation
Contraindicated. Discontinue breast-feeding
Price Intelligence
Rs 6,122.53
DRAP approved maximum price · per unit · approved 29 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper unitRs 6,122.53
Should you consider an alternative?
Other options containing Paclitaxel, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
78
brands
86
molecules
0
alerts